PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT07025876 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

240

Enrollment

NETWORK

Sponsor class

Conditions

Streptococcus Pneumoniae Pneumonia

Interventions

BIOLOGICAL: low dose PCV24
BIOLOGICAL: high dose PCV24
BIOLOGICAL: PPV23
BIOLOGICAL: Placebo

Sponsor

Jiangsu Province Centers for Disease Control and Prevention